Atomoxetine/Aroxybutynin

N/A

Report date: 2025/07/25 10:36:09

Base Information

Drug NameAtomoxetine/Aroxybutynin
Drug Alias NameAD109(Apnimed)AD-109(Apnimed)
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitorsAntimuscarinic agents
TargetsNorepinephrine transporterMuscarinic acetylcholine receptor
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesApnimed Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalApnimed Inc
Inactive CompaniesN/A
Active IndicationsSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A